- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Syncor sees jump in operating income
Radiopharmaceutical firm Syncor International had reason to celebrate this month when it posted a dramatic increase in operating income for third quarter 1999 (end-September). The Woodland Hills, CA, firm’s operating income climbed 48% during the
Radiopharmaceutical firm Syncor International had reason to celebrate this month when it posted a dramatic increase in operating income for third quarter 1999 (end-September). The Woodland Hills, CA, firms operating income climbed 48% during the quarter, to $8.3 million from $5.6 million the year before. Net sales increased by 15% to $131.5 million, up from $114 million in 1998. The company reported net income of $3.2 million, compared with $2.7 million for the same period the previous year. Included in Syncors results was a nonoperating write-down of $1.8 million linked to the companys 1997 investment in Perimunne, a biotechnology company.
The company attributed its strong performance to increased market demand for pharmacy services, as well as sales revenue and acquisitions in its medical imaging business. For the quarter, Syncors radiopharmacy gross margin increased by $4.3 million to comprise 27% of the companys sales. Its medical imaging business, which operates under a subsidiary, Comprehensive Medical Imaging, posted sales of $15.7 million for the quarter, compared to $11 million in 1998. Comprehensive Medical Imaging acquired four imaging centers in Southern and Central California during the quarter.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
